Joseph Vazzano
2018 - AVENUE THERAPEUTICS
In 2018, Joseph Vazzano earned a total compensation of $354.5K as Chief Financial Officer at AVENUE THERAPEUTICS, a 9% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $67,851 |
---|---|
Salary | $175,100 |
Stock Awards | $103,800 |
Other | $7,777 |
Total | $354,528 |
Vazzano received $175.1K in salary, accounting for 49% of the total pay in 2018.
Vazzano also received $67.9K in non-equity incentive plan, $103.8K in stock awards and $7.8K in other compensation.
Rankings
In 2018, Joseph Vazzano's compensation ranked 12,831st out of 14,244 executives tracked by ExecPay. In other words, Vazzano earned more than 9.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 12,831 | 10th |
Manufacturing | 5,192 | 10th |
Chemicals And Allied Products | 1,955 | 8th |
Drugs | 1,676 | 8th |
Pharmaceutical Preparations | 1,284 | 8th |
Vazzano's colleagues
We found two more compensation records of executives who worked with Joseph Vazzano at AVENUE THERAPEUTICS in 2018.
News
Abeona Therapeutics CEO Vishwas Seshadri's 2023 pay jumps 90% to $2.8M
March 19, 2024
Abeona Therapeutics CEO Vishwas Seshadri's 2022 pay slips 4% to $1.5M
April 13, 2023
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019